Literature DB >> 2926973

The heated dorsal hand vein: an alternative arterial sampling site.

D C Brooks1, P R Black, M A Arcangeli, T T Aoki, D W Wilmore.   

Abstract

Studies of substrate flux, isotope activity and metabolic balance frequently require arterial sampling. We evaluated: (1) whether substrate concentrations obtained from heated dorsal hand veins (HDHV) were comparable to samples obtained from the radial artery, (2) whether heat sufficient to arterialize HDHV altered contralateral forearm blood flow thus affecting flux calculations, (3) whether a +14 heating pad equaled a cumbersome +700 heating chamber, and (4) whether HDHV showed a dose-response curve to varying heat loads. In 12 normals, dorsal hand temperature was raised from 31.8 +/- 0.6 degrees C to 39.8 +/- 0.8 degrees C (chamber) and 39.3 +/- 0.3 degrees C (pad). Basal contralateral forearm blood flow (3.37 +/- 0.7 ml/100 ml tissue/min) was not significantly altered in the chamber (3.39 +/- 0.5 ml) or the pad (3.44 +/- 0.5 ml). Skin temperature of the unheated hand, an index of superficial blood flow (31.5 +/- 0.7 degrees C) did not change significantly in the chamber (31.6 +/- 0.7 degrees C) or the pad (31.2 +/- 0.7 degrees C). Forearm blood flow did not change with heating in eight postoperative patients. Comparative arterial and HDHV blood gases and 10 metabolic substrates from simultaneously drawn samples at various temperatures showed HDHV PO2 approached but did not equal arterial PO2 at temperatures greater than 39 degrees C. Glucose, amino acid, and substrate concentrations were comparable at 39 degrees C and did not change with increasing temperature. HDHV can reliably determine arterial substrate concentrations using an inexpensive heating pad. In cool environments (20-22 degrees C), contralateral forearm blood flow is not significantly altered. There is no benefit to heating the hand above 39 degrees C.

Entities:  

Mesh:

Year:  1989        PMID: 2926973     DOI: 10.1177/0148607189013001102

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  10 in total

1.  Local and remote thermoregulatory changes affect NIRS measurement in forearm muscles.

Authors:  Alessandro Messere; Silvestro Roatta
Journal:  Eur J Appl Physiol       Date:  2015-07-04       Impact factor: 3.078

2.  Xenin-25 delays gastric emptying and reduces postprandial glucose levels in humans with and without type 2 diabetes.

Authors:  Sara Chowdhury; Dominic N Reeds; Dan L Crimmins; Bruce W Patterson; Erin Laciny; Songyan Wang; Hung D Tran; Terry A Griest; David A Rometo; Judit Dunai; Michael J Wallendorf; Jack H Ladenson; Kenneth S Polonsky; Burton M Wice
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-12-19       Impact factor: 4.052

3.  Hypoglycemic thalamic activation in type 1 diabetes is associated with preserved symptoms despite reduced epinephrine.

Authors:  Munachiso Nwokolo; Stephanie A Amiel; Owen O'Daly; Megan L Byrne; Bula M Wilson; Andrew Pernet; Sally M Cordon; Ian A Macdonald; Fernando O Zelaya; Pratik Choudhary
Journal:  J Cereb Blood Flow Metab       Date:  2019-04-20       Impact factor: 6.200

4.  Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine.

Authors:  M Stumvoll; U Chintalapudi; G Perriello; S Welle; O Gutierrez; J Gerich
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

5.  Glutamine: a major gluconeogenic precursor and vehicle for interorgan carbon transport in man.

Authors:  N Nurjhan; A Bucci; G Perriello; M Stumvoll; G Dailey; D M Bier; I Toft; T G Jenssen; J E Gerich
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

6.  Metabolic responses to xenin-25 are altered in humans with Roux-en-Y gastric bypass surgery.

Authors:  Karin Sterl; Songyan Wang; Lauren Oestricker; Michael J Wallendorf; Bruce W Patterson; Dominic N Reeds; Burton M Wice
Journal:  Peptides       Date:  2016-06-07       Impact factor: 3.750

7.  Xenin-25 amplifies GIP-mediated insulin secretion in humans with normal and impaired glucose tolerance but not type 2 diabetes.

Authors:  Burton M Wice; Dominic N Reeds; Hung D Tran; Dan L Crimmins; Bruce W Patterson; Judit Dunai; Michael J Wallendorf; Jack H Ladenson; Dennis T Villareal; Kenneth S Polonsky
Journal:  Diabetes       Date:  2012-04-20       Impact factor: 9.461

8.  Hormonal Responses to Cholinergic Input Are Different in Humans with and without Type 2 Diabetes Mellitus.

Authors:  Sara Chowdhury; Songyan Wang; Judit Dunai; Rachel Kilpatrick; Lauren Z Oestricker; Michael J Wallendorf; Bruce W Patterson; Dominic N Reeds; Burton M Wice
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

9.  Cholinergic signaling mediates the effects of xenin-25 on secretion of pancreatic polypeptide but not insulin or glucagon in humans with impaired glucose tolerance.

Authors:  Songyan Wang; Lauren Z Oestricker; Michael J Wallendorf; Karin Sterl; Judit Dunai; C Rachel Kilpatrick; Bruce W Patterson; Dominic N Reeds; Burton M Wice
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

10.  Changes in insulin sensitivity and insulin secretion during pregnancy and post partum in women with gestational diabetes.

Authors:  Gitte Oeskov Skajaa; Jens Fuglsang; Sine Knorr; Niels Møller; Per Ovesen; Ulla Kampmann
Journal:  BMJ Open Diabetes Res Care       Date:  2020-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.